First Time Loading...

Neuropace Inc
NASDAQ:NPCE

Watchlist Manager
Neuropace Inc Logo
Neuropace Inc
NASDAQ:NPCE
Watchlist
Price: 13.64 USD -1.87% Market Closed
Updated: May 5, 2024

Neuropace Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neuropace Inc
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Neuropace Inc
NASDAQ:NPCE
Operating Income
-$27.2m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.1B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
5%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.5B
CAGR 3-Years
46%
CAGR 5-Years
7%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Operating Income
$4.5B
CAGR 3-Years
17%
CAGR 5-Years
7%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.6B
CAGR 3-Years
-1%
CAGR 5-Years
11%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$1.9B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
11%

See Also

What is Neuropace Inc's Operating Income?
Operating Income
-27.2m USD

Based on the financial report for Dec 31, 2023, Neuropace Inc's Operating Income amounts to -27.2m USD.

What is Neuropace Inc's Operating Income growth rate?
Operating Income CAGR 3Y
-28%

Over the last year, the Operating Income growth was 33%. The average annual Operating Income growth rates for Neuropace Inc have been -28% over the past three years .